Cardiovascular morbidity and mortality in obstructive sleep apnea

Area of Science:

• Cardiology
• Sleep Medicine
• Internal Medicine

Background:

• Obstructive sleep apnea syndrome (OSA) affects 2-4% of adults and is a major independent risk factor for cardiovascular disease.
• OSA is linked to hypertension, ischemic heart disease, stroke, pulmonary hypertension, cardiac arrhythmia, and cardiovascular mortality.
• Subclinical signs include endothelial dysfunction, vascular remodeling, oxidative stress, inflammation, and leukocyte adhesion, suggesting atherogenesis is key.

Purpose of the Study:

• To highlight the significant cardiovascular risks associated with obstructive sleep apnea syndrome.
• To elucidate the role of atherogenesis in the cardiovascular sequelae of OSA.
• To emphasize the importance of early OSA diagnosis and treatment for cardiovascular health.

Main Methods:

• Review of existing literature on OSA and cardiovascular outcomes.
• Analysis of studies linking OSA to specific cardiovascular conditions.
• Examination of pathophysiological mechanisms including endothelial dysfunction and oxidative stress.

Main Results:

• OSA is independently associated with a wide range of cardiovascular morbidities and mortality.
• Atherogenesis, driven by inflammation and endothelial dysfunction, plays a central role in OSA's cardiovascular impact.
• Effective OSA treatment can halt and reverse the atherogenic process.

Conclusions:

• OSA is a critical, treatable risk factor for cardiovascular disease.
• Early intervention for OSA is crucial to prevent or reverse cardiovascular damage.
• Addressing OSA is essential for comprehensive cardiovascular risk management.